Results: 6

The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis

Adv Rheumatol; 61 (), 2021
Abstract Background: To assess the prevalence and clinical relevance of anti-Jo-1 autoantibodies in a representative sample of patients with definite dermatomyositis (DM). Methods: This retrospective cohort study took place from 2005 to 2020 and assessed 118 adult patients from a tertiary center who we...

Frequency and clinical relevance of anti-Mi-2 autoantibody in adult Brazilian patients with dermatomyositis

Adv Rheumatol; 59 (), 2019
Abstract Background: To analyze the frequency and clinical relevance of anti-Mi-2 autoantibody in a representative sample of patients with dermatomyositis. Methods: This longitudinal inception cohort study, from 2001 to 2017, included 87 definite adult dermatomyositis. Anti-Mi-2 analysis was performed ...

The expression of gene ANKRD1 correlates with hypoxia status in muscle biopsies of treatment-näive adult dermatomyositis

OBJECTIVES. The ANKRD1 gene codes for the ankyrin repeat domain containing protein 1 and has an important role in myogenesis and possibly also in angiogenesis. Microvasculopathy is a cornerstone and an early pathological marker of change in dermatomyositis, leading to hypoxia and muscle perifascicular at...

Analysis of sexual function of patients with dermatomyositis and polymyositis through self-administered questionnaires: a cross-sectional study

Rev. bras. reumatol; 57 (2), 2017
Abstract Introduction: To date, there are no descriptions in the literature on gynecologic and sexual function evaluation in female patients with dermatomyositis (DM) and polymyositis (PM). Objective: To assess sexual function in female patients with DM/PM. Patients and methods: This is a monocentric,...

El corazón en la dermatomiositis y polimiositis
The heart in dermatomyositis and polymyositis

Once pacientes consecutivos fueron estudiados desde el punto de vista cardiológico a través de métodos no invasivos: ocho con Dermatomiositis (DM) y 3 con Polimiositis (AM). En nueve de ellos (82%) se detectó alguna complicación cardiopulmonar. a) En el cuadro clínico; ocho (73%) refirieron algún ...